In-vitro fertilization liquid capable of improving fertilization ability of bovine sperms and preparation method thereof

By using in vitro fertilization fluid with theophylline and other components in bovine embryo production, the fertilization ability and survival rate of bovine sperm are improved, the problem of insufficient fertilization ability of bovine sperm in the existing technology is solved, and efficient embryo production and transplantation are achieved Rate.

CN119040249APending Publication Date: 2024-11-29SHANDONG OX LIVESTOCK BREEDING CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411144809.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art is difficult to effectively improve the fertilization ability and in vitro survival rate of bovine sperm in vitro embryo production, which affects the embryo production efficiency.

Method used

Using an in vitro fertilization fluid containing theophylline, sodium pyruvate, sucrose, streptomycin and bovine serum albumin, it is prepared by a combination of sperm treatment solution and in vitro fertilization culture solution to significantly improve the motility and fertilization rate of bovine sperm. and prolong its survival time in vitro.

Benefits of technology

It significantly improves the in vitro fertilization ability of bovine sperm, improves the fissure rate and blastocyst rate, reduces production costs, and simplifies the processing process and improves the pregnancy rate of embryo transfer.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040249A_ABST
    Figure CN119040249A_ABST
Patent Text Reader

Abstract

The invention relates to a cattle in-vitro fertilization liquid, in particular to an in-vitro fertilization liquid capable of improving the fertilization capacity of cattle sperms and a preparation method of the in-vitro fertilization liquid, and belongs to the technical field of biology. The in-vitro fertilization liquid comprises a sperm treatment liquid and an in-vitro fertilization culture liquid. When the in-vitro fertilization liquid provided by the invention is used for treating sperms, the movement parameters of the sperms can be improved, so that the in-vitro fertilization ability of the sperms is improved, and a relatively high blastocyst rate and embryo transfer conception rate are obtained.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biotechnology and relates to a bovine in vitro fertilization solution, particularly an in vitro fertilization solution that can improve the in vitro fertilization ability of bovine sperm. The method of this invention can significantly improve the in vitro fertilization ability of bovine sperm, for example, it can significantly improve sperm motility, fertilization rate, and further improve cleavage rate and blastocyst rate. Furthermore, this invention also relates to the improved in vitro fertilization solution for improving the fertilization ability of bovine sperm and its preparation method. Background Technology

[0002] The information disclosed in this background section is intended only to enhance understanding of the overall background of the invention and is not necessarily to be construed as an admission or in any way implying that such information constitutes prior art known to those skilled in the art.

[0003] With the widespread application of artificial insemination and in vitro fertilization (IVF) technologies in bovine in vitro embryo production and research, how to further improve the fertilization capacity of thawed sperm has become an increasingly important focus. The ultimate goal of in vitro sperm treatment is to improve sperm motility and enhance fertilization capacity. Sperm capacitation, or sperm activation treatment, is a crucial step in the bovine in vitro embryo production technology system. After activation treatment, harmful components in the semen are removed, capacitation inhibitory factors attached to the sperm cell membrane are eliminated, sperm metabolic function is improved, sperm survival time in vitro is prolonged, sperm survival rate in vitro is increased, and the sperm undergoes the acrosome reaction, thereby acquiring the ability to fertilize oocytes.

[0004] Artificial sperm activation methods are divided into physical activation and chemical activation. Physical activation commonly uses low-intensity helium-neon lasers to treat sperm, thereby stimulating sperm motility. Chemical activation commonly uses specific chemical reagents, such as non-selective phosphodiesterase (PDE) inhibitors, biotin, and sperm agonists, to incubate sperm in vitro for a certain period, thereby improving sperm motility. Currently, the most widely used sperm activating factors in artificial sperm activation are non-selective phosphodiesterase inhibitors, mainly including caffeine, pentoxifylline, and theophylline.

[0005] Theophylline, or 1,3-dimethylxanthine, is mainly found in tea leaves and coffee beans in nature. It is soluble in water, ethanol, chloroform, alkali hydroxides, and ammonia, and also soluble in dilute hydrochloric acid and nitric acid, but sparingly soluble in ether. Clinically, theophylline is often used to treat respiratory diseases such as chronic obstructive pulmonary disease and asthma. In addition, theophylline is an important sperm activator. It enhances sperm motility by inhibiting the activity of sperm phosphodiesterase (PDE), an intracellular hydrolase responsible for degrading cyclic adenosine monophosphate (cAMP). Theophylline inhibits PDE activity, leading to an increase in intracellular cAMP levels. cAMP is an important second messenger that mediates protein kinase A and downstream signaling pathways, thereby inducing phosphorylation of axonal proteins and promoting sperm motility.

[0006] Hishinuma et al. successfully induced epididymal sperm to penetrate the egg by adding 2 mmol / L theophylline to canine epididymal sperm culture medium. Ebner et al. demonstrated that theophylline is a harmless and effective biological agent that can be used to restore immotile sperm in cases of retrograde ejaculation in humans. In 2015, Ferre et al. found that theophylline can improve the in vitro fertilization rate of sperm. In 2018, Gorji et al. found that adding 40 mmol / L theophylline to the cryopreservation solution during the freezing of freshly ejaculated sperm and testicular puncture sperm reduced the decline in sperm motility after thawing, suggesting that theophylline has a protective effect on sperm against cryopreservation damage.

[0007] Bovine in vitro embryo production technology can effectively utilize cow ovaries, improving the reproductive efficiency of superior cows and accelerating the propagation of excellent breeds through in vitro fertilization. Improving sperm fertilization capacity is a core technology limiting the efficiency of bovine in vitro embryo production and plays a crucial role in increasing embryo production efficiency. Although some domestic experts have improved sperm motility parameters by adding theophylline to bull sperm capacitation fluid, further research is needed on how to rationally utilize theophylline in bovine in vitro embryo production, improve sperm activation treatment techniques, and increase fertilization rates and in vitro embryo production efficiency. Summary of the Invention

[0008] To address the aforementioned problems, this invention provides an in vitro fertilization solution that enhances the in vitro fertilization capacity of bovine sperm. The method of this invention can significantly improve the in vitro fertilization capacity of bovine sperm, for example, by significantly improving sperm motility, fertilization rate, and further increasing cleavage rate and blastocyst rate. Furthermore, this invention also relates to the improved in vitro fertilization solution for enhancing the fertilization capacity of bovine sperm and its preparation method.

[0009] To achieve the above objectives, the present invention adopts the following technical solution:

[0010] In a first aspect, the present invention provides an in vitro fertilization solution that can improve the in vitro fertilization ability of bovine sperm, comprising: a sperm processing solution and an in vitro fertilization culture medium; wherein the sperm processing solution and the in vitro fertilization culture medium each comprise: a storage solution and a working solution;

[0011] The working solution for in vitro fertilization culture medium is 10-15% v / v in vitro fertilization culture medium stock solution A.

[0012] 20-25% v / v in vitro fertilization culture medium stock solution B, 1.5-2mM sodium pyruvate, 10-15mM sucrose,

[0013] An aqueous solution of 1-1.5% v / v penicillin and streptomycin, 5-8mM theophylline, and 4-6mg / mL bovine serum albumin.

[0014] Currently, the main fertilization component added to the insemination fluid of commercial products is heparin sodium. However, during in vitro fertilization using heparin sodium, different bulls have varying sensitivities to it. Therefore, it is necessary to adjust the appropriate heparin sodium concentration according to individual bulls. This invention systematically analyzes the action patterns of different fertilization components and their interactions after compounding. Through large-scale experiments, it was found that using theophylline as the main fertilization component, supplemented with other components, to prepare an in vitro fertilization fluid does not have the aforementioned problems and significantly improves the in vitro fertilization capacity of bovine sperm.

[0015] In some embodiments, the sperm treatment solution includes: sperm treatment solution A and sperm treatment solution B;

[0016] In some embodiments, the sperm treatment reservoir A is an aqueous solution containing potassium chloride, sodium chloride, sodium dihydrogen phosphate, 4-hydroxyethylpiperazine ethanesulfonic acid, calcium chloride dihydrate, and magnesium chloride hexahydrate;

[0017] In some embodiments, the sperm treatment fluid reservoir B is an aqueous solution containing sodium bicarbonate.

[0018] This invention develops an in vitro fertilization fluid that can improve the in vitro fertilization ability of bovine sperm. The method of this invention can significantly improve the in vitro fertilization ability of bovine sperm, for example, it can significantly improve sperm motility, fertilization rate, and further improve cleavage rate and blastocyst rate.

[0019] In some embodiments, the molar ratio of potassium chloride, sodium chloride, sodium dihydrogen phosphate, 4-hydroxyethylpiperazine ethanesulfonic acid, calcium chloride dihydrate, and magnesium chloride hexahydrate in the sperm treatment reservoir A is 35-40:700-800:3-5:100-120:15-20:5-8.

[0020] Preferably, the sperm treatment solution A is an aqueous solution containing 35 mM potassium chloride, 700 mM sodium chloride, 3 mM sodium dihydrogen phosphate, 100 mM 4-hydroxyethylpiperazine ethanesulfonic acid, 15 mM calcium chloride dihydrate, and 5 mM magnesium chloride hexahydrate.

[0021] Preferably, the sperm treatment solution B is an aqueous solution containing 100 mM sodium bicarbonate.

[0022] In some embodiments, the sperm processing working solution includes: sperm processing working solution A, sperm processing working solution B, and sperm processing working solution C;

[0023] The sperm treatment working solution A contains 10-15% (v / v) sperm treatment reservoir A, 85-90% (v / v) percoll, 25-30mM sodium bicarbonate, and 25-30mM sodium lactate.

[0024] Preferably, the sperm treatment working solution A is an aqueous solution containing 10% (v / v) sperm treatment reservoir A, 90% (v / v) percoll, 25 mM sodium bicarbonate, and 25 mM sodium lactate.

[0025] The sperm treatment working solution B is an aqueous solution containing 10-15% (v / v) sperm treatment working solution A, 20-25% sperm treatment stock solution B, 2-2.5mM sodium pyruvate, and 15-20mM sucrose.

[0026] Preferably, the sperm treatment working solution B comprises an aqueous solution of 10% (v / v) sperm treatment working solution A, 25% sperm treatment stock solution B, 2 mM sodium pyruvate, and 15 mM sucrose.

[0027] The sperm treatment working solution C is a solution containing 50-55% (v / v) sperm treatment working solution A, 45-50% sperm treatment working solution B, and 100-120 μl of phenol red.

[0028] Preferably, the sperm treatment working solution C is a solution containing 50% (v / v) sperm treatment working solution A, 50% sperm treatment working solution B, and 100 μl of phenol red.

[0029] In some embodiments, the in vitro fertilization culture medium reservoir includes: in vitro fertilization culture medium reservoir A and in vitro fertilization culture medium reservoir B;

[0030] The in vitro fertilization culture medium stock solution A is an aqueous solution containing sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, and sodium dihydrogen phosphate dihydrate.

[0031] The in vitro fertilization culture medium B is an aqueous solution containing sodium bicarbonate.

[0032] In some embodiments, the molar ratio of sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, and sodium dihydrogen phosphate dihydrate in the in vitro fertilization culture medium A is 115-120:4-8:3-6:0.6-1.2:1-2.

[0033] Preferably, the in vitro fertilization culture medium stock solution A is an aqueous solution containing 115 mM sodium chloride, 4 mM potassium chloride, 3 mM calcium chloride dihydrate, 0.6 mM magnesium chloride hexahydrate, and 1 mM sodium dihydrogen phosphate dihydrate.

[0034] Preferably, the in vitro fertilization culture medium stock solution B is an aqueous solution containing 40 mM sodium bicarbonate.

[0035] Preferably, the working solution of the in vitro fertilization culture medium is an aqueous solution of 10% (v / v) in vitro fertilization culture medium stock solution A, 25% (v / v) in vitro fertilization culture medium stock solution B, 1.5 mM sodium pyruvate, 15 mM sucrose, 1% (v / v) penicillin and streptomycin, 5 mM theophylline, and 4 mg / mL bovine serum albumin.

[0036] In some implementations, the reagents are all of cell culture grade or higher purity.

[0037] In some implementations, the in vitro fertilization culture medium can be used for live oocyte retrieval and in vitro fertilization of ovarian-derived oocytes.

[0038] In some implementations, each storage solution can be stored for a long time at 2-8 degrees Celsius after preparation, and each working solution can be stored for 30 days at 2-8 degrees Celsius after preparation.

[0039] A second aspect of the present invention provides a method for preparing an in vitro fertilization solution that can improve the in vitro fertilization ability of bovine sperm, comprising:

[0040] Add sperm treatment working solution A to the container, then add sperm treatment working solution C on top of sperm treatment working solution A and keep it warm;

[0041] Semen is added to the upper layer of the sperm processing working solution C, causing the liquid to separate into three layers: the bottom layer is the sperm processing working solution A, the middle layer is the sperm processing working solution C, and the top layer is the semen; centrifuge, collect the precipitate, add in vitro fertilization culture working solution, centrifuge again, remove the supernatant, and obtain the processed semen;

[0042] The treated semen is added to the oocytes in the fertilized fluid to obtain the final product.

[0043] More specifically, the steps include: ① Add 1.5 ml of sperm processing working solution A to a 15 ml centrifuge tube, then slowly add sperm processing working solution C on top. Incubate the centrifuge tube in a 37°C metal bath. ② Gently add the semen to the top layer of sperm processing working solution C. At this point, the liquid in the centrifuge tube will clearly separate into three layers: the bottom layer is sperm processing working solution A, the middle layer is sperm processing working solution C, and the top layer is semen. ③ Centrifuge the tube at 2500 rpm for 15 minutes. ④ After centrifugation, transfer the bottom layer to a new 15 ml centrifuge tube, add 3 ml of in vitro fertilization culture medium, centrifuge at 1500 rpm for 5 minutes, and discard the supernatant after centrifugation. ⑤ Adjust the sperm density by adding an appropriate amount of the treated semen to the oocytes in the fertilization medium to achieve a final sperm density of 5 × 10⁻⁶. 6 per ml.

[0044] A third aspect of the present invention provides the use of the above-described in vitro fertilization fluid in the preparation of a medicament for improving blastocyst rate and embryo transfer pregnancy rate. This includes:

[0045] (1) Treating sperm with in vitro fertilization fluid can improve various sperm motility parameters;

[0046] (2) Using the in vitro fertilization fluid involved to perform in vitro fertilization on oocytes can achieve a higher blastocyst rate and a similar embryo transfer pregnancy rate than commercial fertilization fluid.

[0047] Beneficial effects of the present invention

[0048] (1) This invention provides an in vitro fertilization solution that can improve the in vitro fertilization ability of bovine sperm. Using live oocytes and oocytes obtained from ovaries in slaughterhouses for in vitro embryo production and transfer can achieve a high blastocyst rate and a similar conception rate. Furthermore, the reagents involved in the in vitro fertilization solution of this invention are simple, readily available, and inexpensive, thus reducing production costs while ensuring the efficiency of bovine in vitro embryo production.

[0049] (2) The preparation method of the present invention is simple, practical and easy to promote. Attached Figure Description

[0050] The accompanying drawings, which form part of this invention, are used to provide a further understanding of the invention. Exemplary embodiments of the invention and their descriptions are used to explain the invention and do not constitute an improper limitation of the invention.

[0051] Figure 1 for minitube Andro Data analysis results of the system's sperm motility module; (A) System-detected sperm motility display chart: different colors represent different sperm motility states; (B) Statistical chart of the proportion of sperm in different motility states;

[0052] Figure 2 The layering of working solution and semen after adding sperm processing fluid. Detailed Implementation

[0053] It should be noted that the following detailed descriptions are exemplary and intended to provide further illustration of the invention. Unless otherwise specified, all technical and scientific terms used in this invention have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.

[0054] As described in the background art, this invention addresses the problem of how to rationally utilize theophylline in bovine in vitro embryo production, improve sperm activation treatment technology, and increase fertilization rate and in vitro embryo production efficiency. The invention provides an in vitro fertilization solution that can improve the in vitro fertilization ability of bovine sperm, specifically comprising:

[0055] Preparation of bovine in vitro fertilization solution

[0056] (1) Sperm treatment solution A: contains an aqueous solution of 35mM potassium chloride, 700mM sodium chloride, 3mM sodium dihydrogen phosphate, 100mM 4-hydroxyethylpiperazine ethanesulfonic acid, 15mM calcium chloride dihydrate, and 5mM magnesium chloride hexahydrate.

[0057] (2) Sperm treatment solution B: An aqueous solution containing 100 mM sodium bicarbonate.

[0058] (3) Sperm treatment working solution A: Contains 10% (v / v) sperm treatment reservoir A, 90%

[0059] An aqueous solution of (v / v)percoll, 25mM sodium bicarbonate, and 25mM sodium lactate.

[0060] (4) Sperm treatment working solution B: An aqueous solution containing 10% (v / v) sperm treatment working solution A, 25% sperm treatment stock solution B, 2mM sodium pyruvate, and 15mM sucrose.

[0061] (5) Sperm treatment working solution C: A solution containing 50% (v / v) sperm treatment working solution A and 50% sperm treatment working solution B.

[0062] (6) In vitro fertilization culture medium stock solution A: contains an aqueous solution of 115mM sodium chloride, 4mM potassium chloride, 3mM calcium chloride dihydrate, 0.6mM magnesium chloride hexahydrate, and 1mM sodium dihydrogen phosphate dihydrate.

[0063] (7) In vitro fertilization culture medium stock solution B: an aqueous solution containing 40 mM sodium bicarbonate.

[0064] (8) In vitro fertilization culture working solution: Contains 10% (v / v) in vitro fertilization culture stock solution A, 25% (v / v) in vitro fertilization culture stock solution B, 1.5 mM sodium pyruvate, 15 mM sucrose, 1%

[0065] (v / v) Aqueous solution of penicillin, streptomycin, 5 mM theophylline, and 4 mg / mL bovine serum albumin.

[0066] All reagents used in this invention are of cell culture grade or higher purity, such as products from Sigma-Aldrich. Each stock solution, once prepared, can be stored for an extended period at 2-8 degrees Celsius, and each working solution, once prepared, can be stored for 30 days at 2-8 degrees Celsius.

[0067] 1. Obtaining oocytes from live donors or ovaries from slaughterhouses

[0068] (1) Live egg collection:

[0069] Instrument preparation: Prepare a live oocyte retrieval instrument, a negative pressure pump, and a metal bath. Connect the oocyte retrieval needle, oocyte retrieval tube, and negative pressure pump. Adjust the negative pressure pump pressure to 80 mmHg. Place 5-10 ml of preheated PBS buffer in the oocyte collection tube and place the collection tube in a 37-degree metal bath.

[0070] Donor cow preparation: The donor cow is restrained using a restraint frame, feces are cleared from the rectum, and the vulva is disinfected. An ultrasound examination is performed to check the follicles and corpus luteum status in the donor cow's ovaries. After confirming that the cow is suitable for oocyte retrieval, 2 ml of lidocaine hydrochloride is administered as an epidural anesthesia at the tailbone.

[0071] Live oocyte retrieval: Using a live oocyte retrieval instrument and a negative pressure pump, oocytes are retrieved from the cow's ovary under ultrasound guidance, and the oocyte collection fluid is collected into an oocyte collection tube.

[0072] (2) Obtaining ovarian oocytes from slaughterhouses:

[0073] After being transported from the slaughterhouse to the laboratory at a transport temperature of 20-30 degrees Celsius, bovine ovaries are first rinsed with sterile 0.9% physiological saline at around 30 degrees Celsius. After rinsing, follicles are extracted from the ovaries using a sterile syringe with a 12-gauge needle, and the follicular fluid is collected into an oocyte collection tube.

[0074] 2. In vitro maturation of oocytes

[0075] After filtering the oocyte recovery solution from the collection tube through an oocyte collection cup, select oocytes containing three or more layers of granulosa cells and with uniform cytoplasm for maturation culture. The culture environment is 38.5 degrees Celsius, 5-7% carbon dioxide, and saturated humidity, with a culture time of 20-24 hours.

[0076] 3. In vitro fertilization

[0077] ① Add 1.5 ml of sperm processing working solution A to a 15 ml centrifuge tube, then slowly add sperm processing working solution C on top. Incubate the centrifuge tube in a 37°C metal bath. ② Take frozen sperm from liquid nitrogen and thaw it in a 38°C water bath. ③ Gently add the thawed semen to the top layer of sperm processing working solution C. At this point, the liquid in the centrifuge tube will clearly separate into three layers: the bottom layer is sperm processing working solution A, the middle layer is sperm processing working solution C, and the top layer is semen. ④ Centrifuge the tube at 2500 rpm for 15 minutes. ⑤ After centrifugation, transfer the bottom layer to a new 15 ml centrifuge tube, add 3 ml of in vitro fertilization culture medium, centrifuge at 1500 rpm for 5 minutes, and discard the supernatant after centrifugation. ⑥ Adjust the sperm density by adding an appropriate amount of the processed semen to the oocytes in the fertilization fluid to achieve a final sperm density of 5 × 10⁻⁶. 6 Sperm / ml. ⑦ Cultured sperm and oocytes at 38.5 degrees Celsius and 5-7% carbon dioxide in a saturated humidity environment for 16-20 hours.

[0078] 4. In vitro embryo culture

[0079] After fertilization, the granulosa cells on the outer layer of the fertilized egg are removed using a Pasteur pipette with an inner diameter of 130-160 μm. The egg is then washed with commercial embryo manipulation solution and placed in commercial embryo culture medium for incubation. The culture environment is 38.5 degrees Celsius, 5-7% carbon dioxide, 5-7% nitrogen, and saturated humidity.

[0080] 5. Embryo freezing and transfer

[0081] (1) Programmed freezing and thawing

[0082] The cultured embryos were cryopreserved using commercial embryo preservation solution and programmed embryo freezing solution. The specific steps were as follows: the embryos were washed 3-5 times with commercial embryo preservation solution and then transferred into commercial programmed embryo freezing solution. The embryos were loaded into tubes in the following five-step order: freezing solution, air bubbles, freezing solution, air bubbles, freezing solution containing embryos, air bubbles, freezing solution, air bubbles, freezing solution. The tubes were then sealed with straw stoppers and placed in a programmed temperature controller. The freezing program was then started. After the freezing program was completed, the straw stoppers were immersed in liquid nitrogen.

[0083] Thawing: Remove the capillary tube from the liquid nitrogen, expose it to air for 10 seconds, then immerse it in 30-degree warm water for 30 seconds.

[0084] (2) Vitrification freezing and thawing

[0085] The embryos were frozen using commercially available embryo vitrification solution. The specific steps were as follows: the embryos were placed in a cryoequilibration droplet for 5 minutes; then the embryos were transferred into the cryoequilibration droplet and placed for 45 seconds; within 10 seconds, the embryos were removed from the cryoequilibration droplet, loaded onto an embryo cryopreservation carrier, and placed in liquid nitrogen.

[0086] Thawing: Remove the embryo cryopreservation carrier from liquid nitrogen and quickly immerse it in the embryo thawing solution, while shaking the cryopreservation carrier; after the embryo detaches from the cryopreservation carrier, continue to stay in the thawing solution for 5 minutes; remove the culture from the thawing solution and transfer it to the embryo preservation solution.

[0087] (3) Embryo transfer

[0088] Fresh embryo transfer: Blastocysts and expanded blastocysts cultured to days 6-8 are loaded into tubes in a five-stage sequence: embryo preservation solution, air bubbles, embryo preservation solution, air bubbles, embryo preservation solution containing embryos, air bubbles, embryo preservation solution, air bubbles, and embryo preservation solution again. The tubes are then sealed with straw stoppers and transferred into recipient cows on day 7 of estrus. On day 30 post-transfer, ultrasound is used to check pregnancy in the recipient cows, and the conception rate is calculated.

[0089] Programmed frozen embryo transfer: After thawing, the embryos are transferred into recipient cows on day 7 of estrus within 15 minutes. On day 30 after embryo transfer, ultrasound is used to check the pregnancy of the recipient cows and the conception rate is calculated.

[0090] Vitrified frozen embryo transfer: After thawing, the embryos are washed three times with embryo preservation solution, then loaded into five-segment tubes, sealed with straw plugs, and transferred into recipient cows on day 7 of estrus. On day 30 post-transfer, ultrasound is used to check for pregnancy in the recipient cows, and the conception rate is calculated.

[0091] The present invention will be further described in detail below with reference to specific embodiments. It should be noted that the specific embodiments are explanations of the present invention and not limitations thereof.

[0092] Example 1

[0093] 1. Preparation of bovine in vitro fertilization solution

[0094] (1) Sperm treatment solution A: contains an aqueous solution of 35mM potassium chloride, 700mM sodium chloride, 3mM sodium dihydrogen phosphate, 100mM 4-hydroxyethylpiperazine ethanesulfonic acid, 15mM calcium chloride dihydrate, and 5mM magnesium chloride hexahydrate.

[0095] (2) Sperm treatment solution B: An aqueous solution containing 100 mM sodium bicarbonate.

[0096] (3) Sperm treatment working solution A: Contains 10% (v / v) sperm treatment reservoir A, 90%

[0097] An aqueous solution of (v / v)percoll, 25mM sodium bicarbonate, and 25mM sodium lactate.

[0098] (4) Sperm treatment working solution B: An aqueous solution containing 10% (v / v) sperm treatment working solution A, 25% sperm treatment stock solution B, 2mM sodium pyruvate, and 15mM sucrose.

[0099] (5) Sperm treatment working solution C: a solution containing 50% (v / v) sperm treatment working solution A, 50% sperm treatment working solution B, and 100 μl of phenol red.

[0100] (6) In vitro fertilization culture medium stock solution A: contains an aqueous solution of 115mM sodium chloride, 4mM potassium chloride, 3mM calcium chloride dihydrate, 0.6mM magnesium chloride hexahydrate, and 1mM sodium dihydrogen phosphate dihydrate.

[0101] (7) In vitro fertilization culture medium stock solution B: an aqueous solution containing 40 mM sodium bicarbonate.

[0102] (8) In vitro fertilization culture working solution: Contains 10% (v / v) in vitro fertilization culture stock solution A, 25% (v / v) in vitro fertilization culture stock solution B, 1.5 mM sodium pyruvate, 15 mM sucrose, 1%

[0103] (v / v) Aqueous solution of penicillin, streptomycin, 5 mM theophylline, and 4 mg / mL bovine serum albumin.

[0104] All reagents used in this invention are of cell culture grade or higher purity, such as products from Sigma-Aldrich. Each stock solution, once prepared, can be stored for an extended period at 2-8 degrees Celsius, and each working solution, once prepared, can be stored for 30 days at 2-8 degrees Celsius.

[0105] 2. Live egg retrieval:

[0106] Instrument preparation: Prepare a live oocyte retrieval instrument, a negative pressure pump, and a metal bath. Connect the oocyte retrieval needle, oocyte retrieval tube, and negative pressure pump. Adjust the negative pressure pump pressure to 80 mmHg. Place 5-10 ml of preheated PBS buffer in the oocyte collection tube and place the collection tube in a 37-degree metal bath.

[0107] Donor cow preparation: The donor cow is restrained using a restraint frame, feces are cleared from the rectum, and the vulva is disinfected. An ultrasound examination is performed to check the follicles and corpus luteum status in the donor cow's ovaries. After confirming that the cow is suitable for oocyte retrieval, 2 ml of lidocaine hydrochloride is administered as an epidural anesthesia at the tailbone.

[0108] Live oocyte retrieval: Using a live oocyte retrieval instrument and a negative pressure pump, oocytes are retrieved from the cow's ovary under ultrasound guidance, and the oocyte collection fluid is collected into an oocyte collection tube.

[0109] 3. In vitro maturation of oocytes

[0110] After filtering the oocyte recovery solution from the collection tube through an oocyte collection cup, select oocytes containing three or more layers of granulosa cells and with uniform cytoplasm for maturation culture. The culture environment is 38.5 degrees Celsius, 5-7% carbon dioxide, and saturated humidity, with a culture time of 20-24 hours.

[0111] 4. In vitro fertilization

[0112] ① Add 1.5 ml of sperm processing working solution A to a 15 ml centrifuge tube, then slowly add sperm processing working solution C on top. Incubate the centrifuge tube in a 37°C metal bath. ② Take frozen sperm from liquid nitrogen and thaw it in a 38°C water bath. ③ Gently add the thawed semen to the top layer of sperm processing working solution C. At this point, the liquid in the centrifuge tube will clearly separate into three layers: the bottom layer is sperm processing working solution A, the middle layer is sperm processing working solution C, and the top layer is semen. ④ Centrifuge the tube at 2500 rpm for 15 minutes. ⑤ After centrifugation, transfer the bottom layer to a new 15 ml centrifuge tube, add 3 ml of in vitro fertilization culture medium, centrifuge at 1500 rpm for 5 minutes, and discard the supernatant after centrifugation. ⑥ Adjust the sperm density by adding an appropriate amount of the processed semen to the oocytes in the fertilization fluid to achieve a final sperm density of 5 × 10⁻⁶. 6 Sperm / ml. ⑦ Cultured sperm and oocytes at 38.5 degrees Celsius and 5-7% carbon dioxide in a saturated humidity environment for 16-20 hours.

[0113] 5. In vitro embryo culture

[0114] After fertilization, the granulosa cells on the outer layer of the fertilized egg are removed using a Pasteur pipette with an inner diameter of 130-160 μm. The egg is then washed with commercial embryo manipulation solution and placed in commercial embryo culture medium for incubation. The culture environment is 38.5 degrees Celsius, 5-7% carbon dioxide, 5-7% nitrogen, and saturated humidity.

[0115] The embryonic development during the culture process was statistically analyzed, and the specific results are shown in Table 1.

[0116] 6. Embryo freezing and transfer

[0117] (1) Programmed freezing and thawing

[0118] The cultured embryos were cryopreserved using commercial embryo preservation solution and programmed embryo freezing solution. The specific steps were as follows: the embryos were washed 3-5 times with commercial embryo preservation solution and then transferred into commercial programmed embryo freezing solution. The embryos were loaded into tubes in the following five-step order: freezing solution, air bubbles, freezing solution, air bubbles, freezing solution containing embryos, air bubbles, freezing solution, air bubbles, freezing solution. The tubes were then sealed with straw stoppers and placed in a programmed temperature controller. The freezing program was then started. After the freezing program was completed, the straw stoppers were immersed in liquid nitrogen.

[0119] Thawing: Remove the capillary tube from the liquid nitrogen, expose it to air for 10 seconds, then immerse it in 30-degree warm water for 30 seconds.

[0120] (2) Vitrification freezing and thawing

[0121] The embryos were frozen using commercially available embryo vitrification solution. The specific steps were as follows: the embryos were placed in a cryoequilibration droplet for 5 minutes; then the embryos were transferred into the cryoequilibration droplet and placed for 45 seconds; within 10 seconds, the embryos were removed from the cryoequilibration droplet, loaded onto an embryo cryopreservation carrier, and placed in liquid nitrogen.

[0122] Thawing: Remove the embryo cryopreservation carrier from liquid nitrogen and quickly immerse it in the embryo thawing solution, while shaking the cryopreservation carrier; after the embryo detaches from the cryopreservation carrier, continue to stay in the thawing solution for 5 minutes; remove the culture from the thawing solution and transfer it to the embryo preservation solution.

[0123] (3) Embryo transfer

[0124] Fresh embryo transfer: Blastocysts and expanded blastocysts cultured to days 6-8 were loaded into tubes in a five-stage sequence: embryo preservation solution, air bubbles, embryo preservation solution, air bubbles, embryo preservation solution containing embryos, air bubbles, embryo preservation solution, air bubbles, and embryo preservation solution again. The tubes were sealed with straw stoppers and then transferred into recipient cows on day 7 of estrus. On day 30 post-transfer, pregnancy was assessed using ultrasound, and the conception rate was recorded. Specific results are shown in Table 2.

[0125] Programmed frozen embryo transfer: Embryos were thawed and transferred into recipient cows on day 7 of estrus within 15 minutes. On day 30 post-transfer, pregnancy was assessed using ultrasound, and the conception rate was recorded. Specific results are shown in Table 3.

[0126] Vitrified frozen embryo transfer: After thawing, the embryos were washed three times with embryo preservation solution, then loaded into five-segment tubes, sealed with straw plugs, and transferred into recipient cows on day 7 of estrus. On day 30 post-transfer, ultrasound was used to check for pregnancy in the recipient cows, and the conception rate was calculated. Specific results are shown in Table 4.

[0127] Example 2

[0128] 1. The preparation of bovine in vitro fertilization fluid is as described in Example 1.

[0129] 2. Oocyte Acquisition: The oocytes used were obtained from ovaries at the slaughterhouse, not through live oocyte retrieval. The specific method was as follows: After transporting the bovine ovaries obtained from the slaughterhouse to the laboratory at a transport temperature of 20-30 degrees Celsius, they were first rinsed with sterile 0.9% physiological saline at approximately 30 degrees Celsius. After rinsing, follicles were aspirated from the ovaries using a sterile syringe with a 12-gauge needle, and the follicular fluid was collected into an oocyte collection tube.

[0130] 3. The in vitro maturation of oocytes, in vitro fertilization, in vitro embryo culture, and blastocyst rate statistics are as described in Example 1.

[0131] Example 3

[0132] 1. The preparation of bovine in vitro fertilization fluid is as described in Example 1.

[0133] 2. The thawed semen was processed according to the method in Example 1, and the sample was processed using Minitube Corporation's... The automated sperm analysis system measured sperm motility parameters, and the specific results are shown in Table 5.

[0134] Example 4

[0135] 1. The preparation of bovine in vitro fertilization fluid is as described in Example 1.

[0136] 2. Referring to the method in Example 2, oocytes derived from slaughterhouse ovaries were fertilized in vitro using sperm treated with the in vitro fertilization solution provided in this invention. Oocytes were collected 6 hours after sperm addition, and the outer granulosa cells were removed using a Pasteur pipette with an inner diameter of 130-160 μm. A coverslip was fixed with 90% Vaseline + 10% paraffin, and the fertilized oocyte specimen was prepared under a stereomicroscope. The specimen was fixed with a mixture of acetic acid and anhydrous ethanol (3:1 volume ratio) for at least 10 hours, stained with lichen red dye at room temperature for 1 hour, and excess dye was removed with a destaining solution (glycerol: glacial acetic acid: water in a 1:1:3 ratio). After sealing, the specimen was observed under a phase-contrast microscope. The fertilization status and number of fertilized sperm were determined based on pronucleus formation after sperm penetration, sperm head swelling, and the presence of the sperm tail. Specific results are shown in Table 6.

[0137] To verify the effectiveness of the present invention, a comparative analysis was conducted, as follows:

[0138] Comparative Example 1

[0139] Referring to the method of Example 1, oocytes obtained from live oocyte retrieval are used to produce in vitro embryos, except that the in vitro fertilization fluid in the in vitro embryo production reagent is replaced with commercially available fertilization fluid.

[0140] Comparative Example 2

[0141] Referring to the method of Example 2; oocytes obtained from slaughterhouse ovaries are used to produce in vitro embryos, except that the in vitro fertilization fluid in the in vitro embryo production reagent is replaced with commercially available fertilization fluid.

[0142] Comparative Example 3

[0143] Following the method of Example 2, sperm motility parameters were measured, except that the in vitro fertilization fluid used was replaced with a commercially available fertilization fluid.

[0144] Comparative Example 4

[0145] Following the method described in Example 4, the fertilized eggs were exposed, stained, and observed for fertilization 6 hours after fertilization.

[0146] Table 1

[0147]

[0148]

[0149] Table 2

[0150]

[0151] Table 3

[0152]

[0153] Table 4

[0154]

[0155] Table 5

[0156]

[0157]

[0158] Table 6

[0159]

[0160] Explanation of indicators in the table:

[0161] Using the in vitro fertilization solution provided by this invention, in vitro fertilization can be performed using oocytes obtained from live egg collection and ovaries from slaughterhouses to produce in vitro embryos for transfer, achieving blastocyst rates and implantation rates similar to those obtained with conventional commercial in vitro fertilization solutions. Simultaneously, using this invention to treat sperm can significantly improve overall sperm motility and fertilization rate.

[0162] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. An in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm, characterized in that: include: Sperm processing fluid and in vitro fertilization culture fluid; the sperm processing fluid and in vitro fertilization culture fluid respectively include: storage fluid and working fluid; The in vitro fertilization culture medium working solution is an aqueous solution of 10-15% v / v in vitro fertilization culture medium stock solution A, 20-25% v / v in vitro fertilization culture medium stock solution B, 1.5-2mM sodium pyruvate, 10-15mM sucrose, 1-1.5% v / v penicillin-streptomycin, 5-8mM theophylline, and 4-6mg / mL bovine serum albumin.

2. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: The sperm processing liquid storage includes: sperm processing liquid storage A, sperm processing liquid storage B; The sperm treatment storage solution A is an aqueous solution containing potassium chloride, sodium chloride, sodium dihydrogen phosphate, 4-hydroxyethylpiperazineethanesulfonic acid, calcium chloride dihydrate, and magnesium chloride hexahydrate; The sperm treatment solution storage solution B is an aqueous solution containing sodium bicarbonate.

3. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: In the sperm treatment storage solution A, the molar ratio of potassium chloride, sodium chloride, sodium dihydrogen phosphate, 4-hydroxyethylpiperazineethanesulfonic acid, calcium chloride dihydrate and magnesium chloride hexahydrate is 35-40:700-800:3-5:100-120:15-20:5-8.

4. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: The sperm treatment liquid working solution includes: sperm treatment liquid working solution A, sperm treatment liquid working solution B, and sperm treatment liquid working solution C; The sperm treatment solution working solution A contains 10-15% v / v sperm treatment storage solution A, 85-90% v / v percoll, 25-30 mM sodium bicarbonate, and 25-30 mM sodium lactate; The sperm treatment solution working solution B is an aqueous solution containing 10-15% v / v sperm treatment solution working solution A, 20-25% sperm treatment solution storage solution B, 2-2.5 mM sodium pyruvate, and 15-20 mM sucrose; The sperm treatment working solution C is a solution containing 50-55% v / v sperm treatment working solution A, 45-50% sperm treatment working solution B, and 100-120 μl of phenol red.

5. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: The in vitro fertilization culture fluid storage solution comprises: in vitro fertilization culture fluid storage solution A and in vitro fertilization culture fluid storage solution B; The in vitro fertilization culture medium storage solution A is an aqueous solution containing sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, and sodium dihydrogen phosphate dihydrate.

6. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: The in vitro fertilization culture medium storage solution B is an aqueous solution containing sodium bicarbonate.

7. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: In the in vitro fertilization culture medium stock solution A, the molar ratio of sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, and sodium dihydrogen phosphate dihydrate is 115-120:4-8:3-6:0.6-1.2:1-2.

8. The in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm according to claim 1, characterized in that: The purity of the reagents was above the cell culture grade.

9. A method for preparing in vitro fertilization solution capable of improving the in vitro fertilization ability of bovine sperm, characterized in that: include: Add sperm treatment liquid working solution A into a container, add sperm treatment liquid working solution C onto the upper layer of sperm treatment liquid working solution A, and keep warm; Adding semen to the upper layer of the sperm treatment liquid working solution C, so that the liquid is divided into three layers, the bottom layer is the sperm treatment liquid working solution A, the middle layer is the sperm treatment liquid working solution C, and the top layer is semen; centrifuging, taking the precipitate, adding the in vitro fertilization culture medium working solution, centrifuging, removing the supernatant, and obtaining the treated semen; The treated semen is added into the oocyte in the fertilization fluid to obtain the product.

10. Use of the in vitro fertilization solution according to any one of claims 1 to 8 in the preparation of a drug for improving the blastocyst rate and embryo transplantation pregnancy rate.